abstract |
The present invention provides a method for producing a PCV2 capsid protein and a pharmaceutical composition containing the capsid protein. The method of the present invention improves the efficiency of synthesis of the PCV2 capsid protein using a novel Arabinose-inducible expression vector. Meanwhile, the pharmaceutical composition of the present invention obtains an excellent immuno-inducing effect by combining the capsid protein and other advantageous components at an appropriate ratio. |